Slotman, Derk J. https://orcid.org/0000-0002-3358-1986
Bartels, Lambertus W.
Zijlstra, Aylene
Verpalen, Inez M.
van Osch, Jochen A. C.
Nijholt, Ingrid M.
Heijman, Edwin
van ‘t Veer-ten Kate, Miranda
de Boer, Erwin
van den Hoed, Rolf D.
Froeling, Martijn
Boomsma, Martijn F.
Article History
Received: 6 May 2022
Revised: 25 October 2022
Accepted: 27 October 2022
First Online: 6 December 2022
Declarations
:
: The scientific guarantor of this publication is M. F. Boomsma, MD PhD.
: One of the authors (Edwin Heijman) is an employee of Philips. The remaining authors declare no relationships with any companies whose products or services may be related to the subject matter of the article
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in the source studies (MASS1 and MASS2). This consent included the authorization to analyse study data outside the scope of the source studies, in the context of MR-HIFU treatments of uterine fibroids. Therefore, no post hoc contact with patients was required for the current retrospective study. Both the source studies and the retrospective study presented here have been approved by the institutional review board (IRB).
: Institutional review board approval was obtained.
: • retrospective• method comparison study• performed at one institution